Bacteriolytic therapy can generate a potent immune response against experimental tumors
- 7 October 2004
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (42) , 15172-15177
- https://doi.org/10.1073/pnas.0406242101
Abstract
When spores of the anaerobic bacterium Clostridium novyi-NT are systemically injected into animals, they germinate exclusively within the hypoxic regions of cancers. The germinated bacteria destroy adjacent tumor cells but spare a rim of well oxygenated tumor cells that subsequently expand. Surprisingly, we found that approximately 30% of mice treated with such spores were cured of their cancers despite the viable tumor rim initially remaining after spore germination. The mechanism underlying this effect was shown to be immune-mediated, because cured animals rejected a subsequent challenge of the same tumor. Similar effects were observed in rabbits with intrahepatic tumors. It was particularly notable that the induced immune response, when combined with the bacteriolytic effects of C. novyi-NT, could eradicate large established tumors.Keywords
This publication has 35 references indexed in Scilit:
- Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cellsCancer Gene Therapy, 2004
- Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking ToleranceJournal of Clinical Oncology, 2004
- Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule AgentsCancer Biology & Therapy, 2004
- Mouse B7-H3 induces antitumor immunityGene Therapy, 2003
- Points of control in inflammationNature, 2002
- Tumor immunology—towards a paradigm of reciprocal researchSeminars in Cancer Biology, 2002
- Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosisGene Therapy, 2002
- Allergy and Allergic DiseasesNew England Journal of Medicine, 2001
- Coley's toxins, tumor necrosis factor and cancer research: A historical perspectivePharmacology & Therapeutics, 1994
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990